Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
2012
Emerging therapies for the treatment of hepatitis C
2013 StandoutNobel
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Immunosuppressive drug monitoring - what to use in clinical practice today to improve renal graft outcome
2005
Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients
2007
Dialysis‐Induced Oxidative Stress: Biological Aspects, Clinical Consequences, and Therapy
2001
Oxidative stress, aging, and diseases
2018 Standout
Lipid peroxidation and antioxidant status in professional American football players during competition
2002
Mechanisms of Vascular Calcification
2007
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Oral Phosphate Binders in Patients with Kidney Failure
2010
Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases
2009
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability
2010
A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
2011 StandoutNobel
Oxidative stress and neurodegeneration: the involvement of iron
2018
Advances in metal-induced oxidative stress and human disease
2011 Standout
Atopic dermatitis
2015 Standout
Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera
2003
Acute-on chronic liver failure
2012
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease
2003
Chronic kidney disease alters intestinal microbial flora
2012 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Chronic kidney disease
2011 Standout
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
A new automated colorimetric method for measuring total oxidant status
2005 Standout
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
2002
The role of iron and reactive oxygen species in cell death
2013 Standout
Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: A randomized controlled trial
2011
The role of antioxidants in the chemistry of oxidative stress: A review
2015 Standout
Efficacy and tolerance of interferon-α2b in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment
1999
Cardiorenal Syndrome
2008 Standout
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
2008
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Oxidative stress: potential of distinct peroxide determination systems
2004
Iron toxicity and antioxidant nutrients
2002
Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients
2007
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Bacterial translocation in experimental uremia
2003
Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin
2003
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis
2013 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Reversal of the Adynamic Bone Disorder and Decreased Vascular Calcification in Chronic Kidney Disease by Sevelamer Carbonate Therapy
2006
Cellular Response to Injury in Membranous Nephropathy
2005
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences
2003 Standout
Hepatitis C and liver transplantation
1995
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Calcium supplementation and vascular disease
2008
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients
2008
Parenteral iron nephrotoxicity: Potential mechanisms and consequences1
2004
Immunotherapy in Elderly Transplant Recipients
2009
Antioxidants: A Possible Role in Kidney Protection
2003
Lipid oxidation and improving the oxidative stability
2010 Standout
Chronic Kidney Disease
2016 Standout
Vitamin C Function and Status in Chronic Disease
2002
Adipose Tissue as an Endocrine Organ
2004 Standout
Anemia of Chronic Disease
2005 Standout
Effects of Hemodialysis, Dialyser Type and Iron Infusion on Oxidative Stress in Uremic Patients
2004
Physicochemical properties of ferumoxytol, a new intravenous iron preparation
2009
Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis
2005 Standout
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
2011
Magnesium in Man: Implications for Health and Disease
2014 Standout
A comparative review of the efficacy and safety of established phosphate binders: calcium, sevelamer, and lanthanum carbonate
2007
The Tumor Lysis Syndrome
2011 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
The relationship between potency of oxidative stress and severity of depression
2004
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
The Effects of Cadmium Toxicity
2020 Standout
Reactive species in non-equilibrium atmospheric-pressure plasmas: Generation, transport, and biological effects
2016 Standout
Fluorescent Sensors for Measuring Metal Ions in Living Systems
2014 Standout
Vitamin D and Immune Function
2013 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients #
2009
Effect of N-acetylcysteine on Malondyaldehyde Content After Iron Treatment in Chronic Kidney Disease Stage 5D Patients
2012
High dose intravenous iron: a note of caution
2002
In vitro study of antioxidant activity of fruit
2005 StandoutNobel
Vascular Calcification
2006 Standout
Vascular Calcification
2008 Standout
Interventions for preventing falls in older people living in the community
2012 Standout
Iron Therapy, Advanced Oxidation Protein Products, and Carotid Artery Intima-Media Thickness in End-Stage Renal Disease
2002
Works of Herwig Holzer being referenced
Effect of Cyclosporine Withdrawal on Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients With Deteriorating Renal Function: Preliminary Report
2001
Increased Susceptibility For Csa-Induced Hepatotoxicity In Kidney Graft RecipieNTSF WITH CHRONIC VIRAL HEAPATITIS C
1993
Spontaneous Bacterial Peritonitis in a Hemodialysis Patient with Systemic Lupus erythematosus
1993
Enteric Coated Mycophenolate Sodium is Therapeutically Equivalent to Mycophenolate Mofetil in de novoRenal Transplant Patients
2004
In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation
2005
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density
2005
Vitamin E Attenuates Oxidative Stress Induced by Intravenous Iron in Patients on Hemodialysis
2000
Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD
2001
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
2008
Decrease in Thoracic Vertebral Bone Attenuation With Calcium-Based Phosphate Binders in Hemodialysis
2005
Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
2002
Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD
2001